These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
473 related articles for article (PubMed ID: 22072931)
21. A role of small heat shock protein B8 (HspB8) in the autophagic removal of misfolded proteins responsible for neurodegenerative diseases. Crippa V; Carra S; Rusmini P; Sau D; Bolzoni E; Bendotti C; De Biasi S; Poletti A Autophagy; 2010 Oct; 6(7):958-60. PubMed ID: 20699640 [TBL] [Abstract][Full Text] [Related]
22. Nuclear TAR DNA binding protein 43 expression in spinal cord neurons correlates with the clinical course in amyotrophic lateral sclerosis. Sumi H; Kato S; Mochimaru Y; Fujimura H; Etoh M; Sakoda S J Neuropathol Exp Neurol; 2009 Jan; 68(1):37-47. PubMed ID: 19104447 [TBL] [Abstract][Full Text] [Related]
23. Enhancing mitochondrial calcium buffering capacity reduces aggregation of misfolded SOD1 and motor neuron cell death without extending survival in mouse models of inherited amyotrophic lateral sclerosis. Parone PA; Da Cruz S; Han JS; McAlonis-Downes M; Vetto AP; Lee SK; Tseng E; Cleveland DW J Neurosci; 2013 Mar; 33(11):4657-71. PubMed ID: 23486940 [TBL] [Abstract][Full Text] [Related]
24. The voltage-gated calcium channel blocker lomerizine is neuroprotective in motor neurons expressing mutant SOD1, but not TDP-43. Tran LT; Gentil BJ; Sullivan KE; Durham HD J Neurochem; 2014 Aug; 130(3):455-66. PubMed ID: 24716897 [TBL] [Abstract][Full Text] [Related]
25. Does wild-type Cu/Zn-superoxide dismutase have pathogenic roles in amyotrophic lateral sclerosis? Furukawa Y; Tokuda E Transl Neurodegener; 2020 Aug; 9(1):33. PubMed ID: 32811540 [TBL] [Abstract][Full Text] [Related]
26. Targeting of monomer/misfolded SOD1 as a therapeutic strategy for amyotrophic lateral sclerosis. Liu HN; Tjostheim S; Dasilva K; Taylor D; Zhao B; Rakhit R; Brown M; Chakrabartty A; McLaurin J; Robertson J J Neurosci; 2012 Jun; 32(26):8791-9. PubMed ID: 22745481 [TBL] [Abstract][Full Text] [Related]
30. [Prion-like Properties of Misfolded Cu/Zn-superoxide Dismutase in Amyotrophic Lateral Sclerosis: Update and Perspectives]. Tokuda E; Marklund SL; Furukawa Y Yakugaku Zasshi; 2019; 139(7):1015-1019. PubMed ID: 31257248 [TBL] [Abstract][Full Text] [Related]
31. Nuclear localization of human SOD1 and mutant SOD1-specific disruption of survival motor neuron protein complex in transgenic amyotrophic lateral sclerosis mice. Gertz B; Wong M; Martin LJ J Neuropathol Exp Neurol; 2012 Feb; 71(2):162-77. PubMed ID: 22249462 [TBL] [Abstract][Full Text] [Related]
32. TDP-43 or FUS-induced misfolded human wild-type SOD1 can propagate intercellularly in a prion-like fashion. Pokrishevsky E; Grad LI; Cashman NR Sci Rep; 2016 Mar; 6():22155. PubMed ID: 26926802 [TBL] [Abstract][Full Text] [Related]
33. Stress signaling from the endoplasmic reticulum: A central player in the pathogenesis of amyotrophic lateral sclerosis. Walker AK; Atkin JD IUBMB Life; 2011 Sep; 63(9):754-63. PubMed ID: 21834058 [TBL] [Abstract][Full Text] [Related]
34. Oxidized/misfolded superoxide dismutase-1: the cause of all amyotrophic lateral sclerosis? Kabashi E; Valdmanis PN; Dion P; Rouleau GA Ann Neurol; 2007 Dec; 62(6):553-9. PubMed ID: 18074357 [TBL] [Abstract][Full Text] [Related]
35. Using yeast models to probe the molecular basis of amyotrophic lateral sclerosis. Bastow EL; Gourlay CW; Tuite MF Biochem Soc Trans; 2011 Oct; 39(5):1482-7. PubMed ID: 21936838 [TBL] [Abstract][Full Text] [Related]
36. The molecular link between inefficient GluA2 Q/R site-RNA editing and TDP-43 pathology in motor neurons of sporadic amyotrophic lateral sclerosis patients. Yamashita T; Kwak S Brain Res; 2014 Oct; 1584():28-38. PubMed ID: 24355598 [TBL] [Abstract][Full Text] [Related]
37. Delayed disease onset and extended survival in the SOD1G93A rat model of amyotrophic lateral sclerosis after suppression of mutant SOD1 in the motor cortex. Thomsen GM; Gowing G; Latter J; Chen M; Vit JP; Staggenborg K; Avalos P; Alkaslasi M; Ferraiuolo L; Likhite S; Kaspar BK; Svendsen CN J Neurosci; 2014 Nov; 34(47):15587-600. PubMed ID: 25411487 [TBL] [Abstract][Full Text] [Related]
38. Mitigation of ALS Pathology by Neuron-Specific Inhibition of Nuclear Factor Kappa B Signaling. Dutta K; Thammisetty SS; Boutej H; Bareil C; Julien JP J Neurosci; 2020 Jun; 40(26):5137-5154. PubMed ID: 32457070 [TBL] [Abstract][Full Text] [Related]
39. Therapeutic vaccines for amyotrophic lateral sclerosis directed against disease specific epitopes of superoxide dismutase 1. Zhao B; Marciniuk K; Gibbs E; Yousefi M; Napper S; Cashman NR Vaccine; 2019 Aug; 37(35):4920-4927. PubMed ID: 31324499 [TBL] [Abstract][Full Text] [Related]